These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4766788)

  • 1. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in middle-sized plants].
    Schlumpf R
    Pharm Acta Helv; 1973; 48(8):471-81. PubMed ID: 4766788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in bigger plants].
    Forster O
    Pharm Acta Helv; 1973; 48(8):455-70. PubMed ID: 4766787
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

  • 5. [Production and control in pharmaceutical industry. Quality control and guarantee of quality. Requirements of IKS-rules in the quality control].
    Sahli M; Bircher M
    Pharm Acta Helv; 1973; 48(8):429-42. PubMed ID: 4766785
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in middle size plants].
    Bucher K
    Pharm Acta Helv; 1973 Feb; 48(2):101-16. PubMed ID: 4706308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in bigger plants].
    Schnorf U
    Pharm Acta Helv; 1973 Feb; 48(2):83-100. PubMed ID: 4706311
    [No Abstract]   [Full Text] [Related]  

  • 8. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in large plants].
    Hinsen W
    Pharm Acta Helv; 1973; 48(6):322-38. PubMed ID: 4729555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in smaller plants].
    Baeschlin K
    Pharm Acta Helv; 1973; 48(6):358-70. PubMed ID: 4729557
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in medium-size plants].
    Schmid HW
    Pharm Acta Helv; 1973; 48(6):339-57. PubMed ID: 4729556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Elaboration of examination rules for initial substances and end products].
    Hubmann E
    Pharm Acta Helv; 1973; 48(8):443-54. PubMed ID: 4766786
    [No Abstract]   [Full Text] [Related]  

  • 13. Developing a formal training program for a small to medium sized pharmaceutical company.
    Kapoor J; Murthy BS; Franklin G
    Bull Parenter Drug Assoc; 1977; 31(1):52-6. PubMed ID: 831900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quality control changes in release controller system].
    Smewing J
    Boll Chim Farm; 2001; 140(3):192-4. PubMed ID: 11486613
    [No Abstract]   [Full Text] [Related]  

  • 15. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Standards of good production. Problems of sampling].
    Fontani F; Sekules G; Zanotti Gerosa A
    Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 18. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 19. [Standards of good production. Human and technical aspects].
    Rocchi B
    Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality engineering 1978.
    Waldner JW
    J Parenter Drug Assoc; 1978; 32(5):205-8. PubMed ID: 251196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.